Safety monitoring of the newer disease modifying therapies in multiple sclerosis patients in Mater Dei hospital [PDF]
, 2016 Patients with highly active Multiple Sclerosis can be started on the newer pharmaceutical agents, Dimethyl Fumarate or Fingolimod. Safety monitoring recommended includes regular blood analysis and also ophthalmic tests and MRI scans in the case of ...
Aquilina, Josanne, Zammit, Daniela
core
Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta [PDF]
, 2014 Background: De-escalating natalizumab (NTZ) to interferon beta 1b (IFN B 1B) is a possible treatment option in multiple sclerosis (MS) patients interrupting NTZ because of increased risk of progressive multifocal leukoencephalopathy (PML).
Calabrese, Pasquale +6 more
core +2 more sources
Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Intravenous rituximab demonstrated significant efficacy in treating a case of refractory cutaneous pseudolymphoma that failed multiple conventional therapies, including corticosteroids, hydroxychloroquine, methotrexate, and biologics. The patient, a 42‐year‐old man, initially developed erythematous, nodular lesions on the face following dental
Elham Behrangi +5 more
wiley +1 more source
Leucoencefalopatia cística sem megalencefalia [PDF]
, 2008 UNIFESP-EPM Department of PediatricsFederal University of São Paulo Department of Neurology and Neurosurgery Division of Child NeurologyHospital Heliopolis Department of RadiologyFederal University of São Paulo EPM Department of Neurology and ...
Arita, Juliana Harumi +5 more
core +2 more sources
Multifocal Leukoencephalopathy
Pediatric Neurology Briefs, 1994 A 15-year-old boy with Wiskott-Aldrich syndrome complicated by progressive multifocal leukoencephalopathy (PML) is reported from the University of Miami School of Medicine, FL, and the National Institute of Neurological Disorders and Stroke, Bethesda, MD.
J Gordon Millichap
doaj +1 more source
Interventions for neurocognitive dysfunction [PDF]
, 2017 Purpose of review: To evaluate current barriers to HIV cure strategies and interventions for neurocognitive dysfunction with a particular focus on recent advancements over the last three years. Recent findings: Optimal anti-retroviral therapy (ART) poses
Brew, B, Ellero, J, Lubomski, M
core +2 more sources
Image guided stereotactic brain biopsy in AIDS patients with neurological manifestations [PDF]
, 1998 Prospective series showing the importance of computerized stereotactic brain biopsy in the management of AIDS patients neurologically symptomatic and confirmed by images. Patients undergone an algorithm step by step done by their own doctors and referred
Confort, Carlos Ivam +4 more
core +2 more sources
Unexpected Progressive Multifocal Leukoencephalopathy in a Hemodialysis Patient [PDF]
, 2020 Bryce A. Durafourt +2 more
openalex +1 more source
Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML
American Journal of Hematology, Volume 100, Issue 10, Page 1853-1858, October 2025.
Nia Choi +11 more
wiley +1 more source
Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study [PDF]
, 2017 Background. We investigated the incidence and outcome of progressive multifocal leukoencephalopathy (PML) in human immunodeficiency virus (HIV)-infected individuals before and after the introduction of combination antiretroviral therapy (cART) in 1996 ...
Battegay, Manuel +9 more
core